Cargando…
Regulated degradation of HMG CoA reductase requires conformational changes in sterol-sensing domain
3-Hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR) is the rate-limiting enzyme in cholesterol synthesis and target of cholesterol-lowering statin drugs. Accumulation of sterols in endoplasmic reticulum (ER) membranes accelerates degradation of HMGCR, slowing the synthesis of cholesterol. Degrad...
Autores principales: | Chen, Hongwen, Qi, Xiaofeng, Faulkner, Rebecca A., Schumacher, Marc M., Donnelly, Linda M., DeBose-Boyd, Russell A., Li, Xiaochun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9314443/ https://www.ncbi.nlm.nih.gov/pubmed/35879350 http://dx.doi.org/10.1038/s41467-022-32025-5 |
Ejemplares similares
-
The prenyltransferase UBIAD1 is the target of geranylgeraniol in degradation of HMG CoA reductase
por: Schumacher, Marc M, et al.
Publicado: (2015) -
Lipid-regulated degradation of HMG-CoA reductase and Insig-1 through distinct mechanisms in insect cells
por: Faulkner, Rebecca A., et al.
Publicado: (2013) -
Type 1 polyisoprenoid diphosphate phosphatase modulates geranylgeranyl-mediated control of HMG CoA reductase and UBIAD1
por: Elsabrouty, Rania, et al.
Publicado: (2021) -
Enhanced ER-associated degradation of HMG CoA reductase causes embryonic lethality associated with Ubiad1 deficiency
por: Jo, Youngah, et al.
Publicado: (2020) -
Schnyder corneal dystrophy-associated UBIAD1 inhibits ER-associated degradation of HMG CoA reductase in mice
por: Jo, Youngah, et al.
Publicado: (2019)